292: Vertex's polarizing data, Aduhelm's adieu, & an FDA icon
The Readout Loud
00:00
Introduction
This chapter discusses the farewell to the drug Adjoham and the concerns surrounding a new paid medicine from Vertex Pharmaceuticals. It also mentions the retirement of an FDA icon and includes a word from a sponsor.
Transcript
Play full episode
